Global biopharmaceutical leader focused on discovering, developing, and delivering innovative medicines for patients with serious diseases, advancing science in oncology, immunology, and other therapeutic areas.
Notice Date
September 1, 2024
—
December 12, 2024
May 3, 2025
Lawrenceville
New Jersey
